Dev Accele. (DEVX)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue growth of 18.99% shows the business still has commercial momentum.
• ROCE of 11.90% indicates operations generate a reasonable return before debt costs.
• Book value per share of ₹26.89 with a P/B of 1.53 provides some asset backing.
• Latest quarter revenue of ₹59 crore suggests a sizeable operating base despite the small loss.

Concerns

• P/E of 110.39 and PEG of 5.81 are far too rich for a company with profit growth of -170.63%.
• Latest quarterly net profit of -₹1 crore and negative profit trend show no current earnings power.
• Debt/equity of 1.77 raises financial distress risk, especially if interest costs rise.
• Piotroski F-Score of 4/9 and zero dividend yield signal poor fundamental health and no safety net.

AI Analysis

At first glance, Dev Accele looks like a growth story. Sales are up 18.99%, and the latest quarter shows ₹59 crore of revenue. But as a value investor, I ask what this growth leaves for owners. The answer is disturbing. The stock trades at a P/E of 110.39, yet profit growth is -170.63% and the latest quarter ended with a net loss of ₹1 crore. A high multiple on collapsing earnings is a dangerous combination. The Piotroski F-Score of 4 out of 9 reinforces my caution; the business is not getting financially stronger. Debt/equity of 1.77 is high, and zero dividend yield means I am not being paid to wait. ROCE of 11.90% is acceptable but not wonderful, and return on equity is N/A--often a red flag when earnings are weak or negative. Book value of ₹26.89 gives some asset support; a P/B of 1.53 means I am paying a premium to book, not buying assets at a discount. Promoter holding of 36.81% is moderate but not strong enough to guarantee patience and discipline. The share price of ₹41.02 is far below the 52-week high of ₹64.05, but a falling stock does not create value. The PEG ratio of 5.81 tells me growth here is expensive, especially when profit is moving in the wrong direction. This is a company with revenue momentum but no demonstrated earnings power, high leverage, and weak fundamental scores. Graham taught me to wait for a margin of safety. I do not see it in Dev Accele. I would keep it on my watchlist, but not buy it today.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer